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Autophagy is important for a variety for virus life cycles. We sought to determine the role of autophagy
in human BK polyomavirus (BKPyV) infection. The addition excess amino acids during viral infection
reduced BKPyV infection. Perturbing autophagy levels using inhibitors, 3-MA, baﬁlomycin A1, and
spautin-1, also reduced infection, while rapamycin treatment of host cells increased infection. siRNA
knockdown of autophagy genes, ATG7 and Beclin-1, corresponded to a decrease in BKPyV infection.
BKPyV infection not only correlated with autophagosome formation, but also virus particles localized to
autophagy-speciﬁc compartments early in infection. These data support a novel role for autophagy in the
promotion of BKPyV infection.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Autophagy is a eukaryotic degradation process that is activated
during nutrient deprivation, metabolic stress, developmental pro-
cesses, and in response to some microbial infections (Wirawan
et al., 2012). Early in autophagy a fold of membrane, known as the
isolation membrane, curves around cytoplasmic cargo destined for
degradation. The ends of the isolation membrane join together to
form a double membranous vesicle. This new structure, known as
an autophagosome, fuses with the lysosome forming the auto-
lysosome, which is rich in hydrolases that act to enzymatically
catabolize the vesicular contents (Juhasz and Neufeld, 2006). By
isolating and then directing organelles and large biomolecules
toward the lysosome, autophagy enables the cell to break down
and redistribute molecules to pathways that are more critical for
cell survival.
For some intracellular pathogens autophagy acts as antimicro-
bial defense by helping to deliver invading microorganisms to the
lysosome for degradation, antigen presentation, or toll-like receptor
engagement (Lee et al., 2007; Gutierrez et al., 2004; Talloczy et al.,
2006; Liang et al., 1998; Virgin and Levine, 2009; Dengjel et al., 2005).
Autophagy degrades some intracellular pathogens, such as
Mycoplasma tuberculosis and herpes simplex virus-1 (HSV-1)
(Gutierrez et al., 2004; Jiang et al., 2011; Talloczy et al., 2006).
Interestingly, some viruses utilize the autophagosome to promote
viral replication, translation, and regulate cell lysis (Hussein et al.,
2012; Meng et al., 2012; Meng et al., 2012; Dreux et al., 2009; Sir
et al., 2012; Zhou and Munger, 2009; O'Donnell et al., 2011). Many
RNA virus including poliovirus, coxsackievirus, coronavirus, and
hepatitis C virus induce autophagy levels in the infected host cell
to beneﬁt the viral life cycle (Dreux et al., 2009; Wong et al., 2008;
Taylor and Kirkegaard, 2008; Maier and Britton, 2012). RNA viruses
are thought to utilize the double membranous autophagosome
structure as a platform for promoting viral transcription or
replication (Maier and Britton, 2012).
The human BK polyomavirus, (BKPyV), is a small double-
stranded DNA virus known to cause tumors in rodents. In humans
BKPyV is the causative agent of polyomavirus associated nephro-
pathy, a viral complication that affects approximately 5–10% of
kidney transplant recipients (Drachenberg et al., 2007; Schaub
et al., 2010). As BKPyV is an intracellular pathogen, its life cycle is
intimately connected with its host cell. Previous studies have
shown the BKPyV requires vesicular acidiﬁcation during the
infectious process, but the virus does not seem to use the
canonical endosome–lysosome pathway (Eash and Atwood,
2005; Eash et al., 2004; Jiang et al., 2009). In this study, we
explored the importance of autophagy in BKPyV infection.
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Results
Excess amino acids reduce BKPyV infection
To test the affect of nutrient availability on BKPyV infection
levels, Vero cells, a green monkey renal epithelial cell line, were
incubated with media containing differing concentrations of
essential amino acids before and after being challenged with
BKPyV (Fig. 1A). Sodium hydroxide was added to amino acid-
supplemented media so that media had identical pH levels.
Increasing the concentration of amino acids led to a decrease in
BKPyV infection in host cells indicating that higher levels of amino
acids hinder BKPyV infectivity. Addition of amino acids did not
lead to a change in Vero cell death or proliferation (Fig. 1B). One
hypothesis is that cells treated with amino acids have lower
autophagy levels, as nutrient deprivation is a major activator of
cellular autophagy. To evaluate the level of autophagy in amino
acid supplemented cells, a plasmid encoding microtubule-
associated protein light chain 3 fused to green ﬂuorescent protein
(LC3-GFP) was transfected into cells. LC3 is distributed in a diffuse
pattern throughout the cytoplasm in the presence of low levels of
autophagy (LC3-I), and acquires a distinct punctate distribution
during autophagy (LC3-II) (Mizushima, 2004; Kabeya et al., 2000).
LC3-GFP transfected cells were treated with 100 nM rapamycin, a
drug known to activate autophagy, in media with different con-
centrations of amino acids. 24 h later the number of LC3-GFPþ
punctae per cell was scored for 80 cells. Addition of amino acids
led to a decrease in the number of LC3-GFPþpunctae per cell
suggesting that amino acid supplementation suppressed autop-
hagy (Fig. 1C).
Modulating autophagy levels affects BKPyV infection
To determine whether autophagy is important in BKPyV infec-
tion, host cells were treated with pharmacological agents that
affect autophagy levels, infected with BKPyV, and stained for VP1
72 h post infection. Rapamycin is a drug that inactivates the
protein mammalian target of rapamycin (mTOR), a kinase that
promotes cell growth and protein synthesis. Rapamycin also
elevates autophagy levels (Meng et al., 2012; Noda and Ohsumi,
1998). Vero cells treated with 100 nM rapamycin showed elevated
BKPyV infection levels compared to DMSO-treated cells indicating
that inhibition of mTOR elevates infection (Fig. 2A and F). 3-MA is
an inhibitor of autophagy that blocks phosphatidylinositol
3-kinase (PI3K) activation, an event that is necessary for mem-
brane trafﬁcking during autophagy (Blommaart et al., 1997; Petiot
et al., 2000). Cells treated with 3-MA showed a dose-dependent
decrease in infection (Fig. 2B and F) suggesting that autophagy
promotes BKPyV infection. Rapamycin was able to restore infec-
tion to 3-MA-treated Vero cells (Fig. 2C). Another autophagy
inhibitor, spautin-1, degrades class III PI3K by inhibiting the
activity of the ubiquitin speciﬁc peptidases, USP10 and USP13
(Mateo et al., 2013; Liu et al., 2011). Spautin-1 also reduced BKPyV
infection in a dose-dependent manner (Fig. 2D and F). Vero cells
treated with baﬁlomycin A1, a vacuolar Hþ ATPase inhibitor that
blocks lysosomal acidiﬁcation that is necessary for both autopha-
gic degradation and endosome maturation, were also less suscep-
tible to BKPyV infection suggesting that vesicular acidiﬁcation is
important for BKPyV infection (Fig. 2E and F) (Tanigaki et al.,
2003). Taken together these data suggest that autophagy may be
important in BKPyV infection. A trypan blue exclusion assay
veriﬁed that the pharmacological agents used in this study no
statistically signiﬁcant difference in cytotoxicity compared to no
drug control (Supplemental Fig. 1). BKPyV-infected HeLa cells,
which are permissive to BKPyV and have similar infection kinetics
to Vero cells, showed nearly identical infection levels after drug
treatments (Supplemental Fig. 2). When VP1 staining was com-
pared in untreated cells infected with BKPyV for 3 h versus 72 h,
VP1 nuclear staining was only observed in the 72 h condition
Fig. 1. Amino acid supplementation decreases BKPyV Infection. (A) Vero cells were
challenged with BKPyV in EMEM media with 5% fetal bovine serum with and
without additional essential amino acids. EMEM without additional supplementa-
tion is labeled 0 . After infection, the cells were replaced with EMEM media with
5% fetal bovine serum with or without the addition of amino acids and left for
duration of infection. Cells were ﬁxed at 72 h post infection using paraformalde-
hyde and permeabilized with Triton X-100. Infection was determined by using an
antibody (PAB597) speciﬁc to the viral protein VP1 and then scoring the number of
VP1þ cells using indirect immunoﬂuorescence. (B) Cell death was evaluated 24 h
following amino acid supplementation by scoring the number of cells excluding
trypan blue and graphing the percentage of cells that excluded the trypan blue dye.
To measure cell proliferation a MTS assay was used. Vero cells in 96 well plate were
incubated with amino acids for 24 h after which 20 μl of CellTiter 96 AQueous One
Solution Reagent – MTS (Promega) reagent was added directly to cells and media
for 2 h, and absorbance was measure at 450 nm. The absorbance of 0 was used as
a control for cell viability. (C) Vero cells were transfected with a plasmid expressing
LC3-GFP and incubated for 24 h. Cells were treated with different concentrations of
amino acid for 24 h in the presence of 100 nM rapamycin. LC3-GFP distribution was
observed using immunoﬂuorescence. The average number of LC3-GFPþ punctae
per cell for 80 cells was scored. Each graph represents the average of three or more
experiments. Error bars on bar graphs represent the SEM. nnp-valueo0.02.
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Fig. 2. Autophagy affects BKPyV infection. (A) Vero cells were pretreated with rapamycin or an equal volume of DMSO for 24 h, infected with BKPyV, and rapamycin added
back for 24 h. Cells were ﬁxed and stained for VP1 at 72 h post infection as in Fig. 1. (B) Vero cells were pretreated with 3-MA for 3 h, infected with BKPyV in the absence of
3-MA, and then media containing 3-MA was added back to cells for 24 h. Cells were ﬁxed and stained for VP1 at 72 h. (C) Vero cells were pretreated with 100 nM of
rapamycin for 24 h and 5 mM of 3-MA for 3 h where indicated, infected with BKPyV, and drugs added back for 24 h. After 72 h cells were stained for VP1 expression.
(D) After Vero cells were infected with BKPyV, cells were treated with spautin-1 or DMSO for 72 h after which cells were ﬁxed and stained from VP1 protein. (E) Vero cells
were infected with BKPyV in the absence of drug. After infection, cells were treated the indicated concentrations of baﬁlomycin A1 or the DMSO control for 24 h. Cells were
ﬁxed and stained for VP1 at 72 h (F) Representative images of indirect immunoﬂuorescence staining of VP1 (BKPyV infected cells) in Vero cells treated with drugs from 0 to
24 h at 72 h post infection. (G) Vero cells were transfected with a plasmid expressing LC3-GFP and incubated for 24 h. Cells were treated with media alone (no drug), serum
free media for 3 h, 100 nM rapamycin for 24 h, 5 uM spautin-1 for 24 h, 5 mM 3-MA for 3 h, DMSO for 24 h and ﬁxed then with paraformaldehyde. LC3-GFP distribution was
observed using immunoﬂuorescence. A representative image of an LC3-GFPþ expressing cell after treatment shows the change in LC3 localization (magniﬁcation 1000).
The number in the top right corner is the average number of punctae scored for 80 cells. (H) The average number of LC3-GFPþ punctae per cell for 80 cells was scored. The
treatments were as follows: 100 nM rapamycin, DMSO, and 5 uM spautin-1 for 24 h, and serum free media and 5 mM 3-MA for 3 h. Graphs represent data from three or
more experiments. Error bars on bar graphs represent the SEM. np-value¼0.02–0.05 and nnp-valueo0.02, or p-value was included.
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indicating that input virus canot cause the strong nuclear signal
dize in Fig. 2F (data not shown).
Pharmacological agents inﬂuence LC3 distribution
To test the effect of these drugs on autophagy levels in Vero
cells, cells were transfected with a plasmid encoding LC3-GFP.
In LC3-GFP-expressing Vero cells, we found rapamycin and serum
starvation increased autophagy levels as determined by a change
in cellular LC3 localization and an increase in LC3-GFPþ punctae,
while 3-MA and spautin-1 inhibited serum starvation and
rapamycin-induced autophagy, respectively (Fig. 2G and H). Our
results were consistent with previous ﬁndings showing these
drugs inﬂuence autophagy levels (Hussein et al., 2012; Meng
et al., 2012; Noda and Ohsumi, 1998; Blommaart et al., 1997;
Mateo et al., 2013; Tanigaki et al., 2003; Seglen and Gordon, 1982;
Blazquez et al., 2013).
Autophagy inhibitors reduce BKPyV infection early in the viral life
cycle
To elucidate the kinetics of autophagy-speciﬁc regulation of
BKPyV infection, Vero cells were treated with autophagy inhibitors
for various intervals before and following viral challenge.
A signiﬁcant decrease in infection was observed when cells were
treated within the ﬁrst 24 h following infection or for the 72 h
duration of infection (Fig. 3). BKPyV was signiﬁcantly inhibited by
the addition of 3-MA, spautin-1 and baﬁlomycin A1 during the
ﬁrst 8 h of infection suggesting that autophagy is important early
in the BKPyV infectious process (Fig. 3). Autophagy may play an
antiviral role at later stages in infection as addition of autophagy
inhibitors at time intervals later in the viral life cycle increases
infection.
Knockdown of autophagy genes decrease BKPyV infection
To further test the effect of restricting autophagy on BKPyV
infection, siRNA molecular silencing was used to reduce levels of
LC3, Beclin-1, and ATG7, genes that regulate autophagy. In HeLa
cells, a mixture of 3–5 siRNA molecules directed against Beclin-1
or ATG7 reduced BKPyV infection. Interestingly, LC3 siRNA treat-
ment did not decrease BKPyV infection (Fig. 4B), suggesting that
greater knockdown of the autophagic LC3-II form is required to
effectively inhibit BKPyV (Fig. 4A). Taken together, these data
suggest autophagy-speciﬁc proteins promote BKPyV infection in
HeLa cells.
BKPyV associates with autophagosome
We next asked whether BKPyV physically interacts with the
autophagosome. To address this the localization of BKPyV and
LC3-GPF vesicles was analyzed using confocal microscopy. LC3-
GFP-expressing Vero cells were infected with infectious AlexFluor-
633-labeled BKPyV (BKPyV-633). Of the 60 cells that were
analyzed, 27% (n¼16) of cells showed viral particles had pene-
trated the cell membrane and entered the host cell. Analysis of the
infected cells revealed that 38% of these cells (6/16 cells) showed
strong colocalization of BKPyV and LC3-GFPþ in small or large
autophagosomes. This differed from the 0% of cells (0/16 cells) that
showed BKPyV colocalized with the diffusely expressed, non-
autophagic LC3-GFPþ . Our data suggest that BKPyV is more likely
to colocalize with LC3-GFPþ when it is found in an autophago-
some. This colocalization of BKPyV with the LC3-GFPþ autopha-
gosomes was observed at 3 h post infection, indicating that the
virus associates with an autophagic vesicle at a time point
consistent with endocytic trafﬁcking (Fig. 5A–D).
In LC3-GFPþ transfected Vero cells, localization of LC3 was
found in one of three patterns: diffuse (Fig. 2G), small and ﬁlled-in
autophagosomes (Fig. 5D), or in larger donut-shaped autophago-
somes (Fig. 5C). After establishing that BKPyV localized to LC3-GFP
autophagosome (Fig. 5A and B), we next examined if the cellular
location of BKPyV correlated with autophagosome formation. LC3-
GFP expressing Vero cells were challenged with BKPyV-633 and
then location of BKPyV-633 and type of LC3-GFP pattern recorded.
In Vero cells that showed no internalized BKPyV-633, LC3-GFP was
found to be primarily diffuse or in small punctae (Fig. 5E, left).
In cells infected with BKPyV, as determined by the presence of
intracellular BKPyV-633, LC3-GFP localization changed and it
localized to small punctae and larger autophagosomes (Fig. 5E,
middle and right). Cells that showed colocalization of BKV-AF633
and LC3-GFP were scored for the pattern of LC3-GFP distribution.
When BKV-AF633 and LC3-GFP showed overlapping localization,
LC3-GFP was distributed to small or larger autophagosomes
(Fig. 5E, right). These data suggest that BKPyV infection may not
only rely on autophagy for viral infection, but may also play an
active role in promoting cellular autophagy.
Discussion
Autophagy functions as an antimicrobial defense against some
viruses and promotes the replication and infection of other viruses
(Gutierrez et al., 2004; Liang et al., 1998; Talloczy et al., 2006;
Hussein et al., 2012; Meng et al., 2012; O'Donnell et al., 2011; Sir
and Ou, 2010). Autophagy may have evolved as an antimicrobial
defense process because its degradative function within the cell
eliminates some invading microbes. For example, autophagy is
believed to control and degrade both Sindbis virus and herpes
simplex virus-1 (HSV-1) (Liang et al., 1998; Talloczy et al., 2006).
HSV-1 is equipped with a viral protein called ICP34.5, which
inactivates autophagy. HSV-1 mutants missing ICP34.5 show
greater autophagic degradation and an attenuated neurovirulence
phenotype in mice (Talloczy et al., 2006; Orvedahl et al., 2007).
Autophagy has also been shown to stimulate the innate immune
system and link it to the adaptive immune system. Autophagy can
Fig. 3. Autophagy Inhibitors decrease BKPyV infection early in the viral life cycle.
Cells were treated for the indicated times before or after BKPyV infection with
5 mM 3-MA, 5 uM Spautin-1, 100 nM baﬁlomycin-A, and the media- or DMSO-
control. Cells were ﬁxed at 72 h post infection, and infection was determined by
scoring the number of VP1 expressing cells. The effect of the drugs on infection
levels was calculated by comparing the average number of infected cells in control-
treated conditions to the average number of infected cells in inhibitor-treated cells.
A positive value indicates the autophagy-inhibitor reduced BKPyV infection. Each
bar graph represent the average of three experiments np-valueo0.02. Error bars on
bar graphs represent the SEM.
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promote antigen processing and presentation on major histocom-
patibility (MHC) molecules (Dengjel et al., 2005). Autophagosomes
have been reported to help transport microbial cargo towards the
lysosome where toll like receptor (TLR) engagement leads to Type I
interferon production and other innate immune responses (Lee
et al., 2007). Moreover, surface TLR engagement and signaling can
activate autophagy (Xu et al., 2007). Mutations and deletions in
autophagy genes are also associated with intestinal inﬂammation,
disrupted Paneth cell secretion, and altered gut microﬂora (Virgin
and Levine, 2009).
Paradoxically, autophagy promotes the replication and infec-
tion of a number of viruses (Hussein et al., 2012; Meng et al., 2012;
O'Donnell et al., 2011; Sir and Ou, 2010). There are multiple ways
that autophagy promotes viral infection. RNA viruses require
intracellular membranes to serve as scaffolds for viral replication
within the cytoplasm (Salonen et al., 2005). Autophagy orches-
trates the trafﬁcking of vesicles to new locations within the cell
thereby providing new membranous structures for viral replica-
tion to occur. Autophagy proteins have also been shown to aid in
the translation of Hepatitis C virus proteins as well as viral
replication (Sir et al., 2012; Dreux et al., 2009). Some DNA viruses
also utilize autophagy. For example, adenovirus and the E7 protein
of human papillomavirus 16 (HPV16) induce autophagy, which
researchers hypothesize stimulates host cell death resulting in
greater release of viral progeny (Zhou and Munger, 2009;
Rodriguez-Rocha et al., 2011).
Recently, autophagy has been demonstrated to occur in human
JC polyomavirus infected cells. JC polyomavirus T-antigen (T-Ag)
was found to suppress expression of a host autophagy gene called
Bag3. Overexpression of Bag3 in host cells, results in elevated
autophagy levels and decreases JC infection. These data suggest
that autophagy acts as an anti-viral process in JC polyomavirus
infection (Sariyer et al., 2012). In contrast, elevation of host
autophagy occurs when cells were made to express small
t-antigen of simian virus 40 (SV40), a polyomavirus family
member related to BKPyV (Kumar and Rangarajan, 2009). The
small t antigen seems to help the cells to survive and respond to
low nutrient conditions by stimulating host AMP-activated protein
kinase (AMPK). When AMPK is activated it inactivates mTOR and
thus increases the amount of autophagy occurring within the cell.
These steps are thought to block premature host cell death during
the viral life cycle, a state that would maximize viral production
(Kumar and Rangarajan, 2009). Whether polyomavirus large and
small t-antigen have opposing roles in controlling autophagy or if
autophagy inﬂuences individual polyomaviruses members differ-
ently has yet to be determined.
In this report, we show that induction of host autophagy early
in the viral life cycle promotes BKPyV infection. Pharmacological
Fig. 4. Knockdown of autophagy proteins, Beclin-1 and ATG7, reduced in BKPYV infection. (A) HeLa cells were transfected with 70 nM siRNA. After 48 h, cells were harvested,
protein lysates were resolved by SDS-PAGE gel, and immunoblot analysis for LC3, Beclin-1, ATG7, and tubulin was performed. Tubulin expression was used as a loading
control. Numeric values represent the ratio of immunoblot band intensity of indicated gene/tubulin. (B) HeLa cells were transfected with 70 nM siRNA, which contained a
mixture of 3–5 siRNA molecules directed to different regions of a gene, and incubated for 48 h. Cells were then infected with BKPyV and ﬁxed at 72 h post infection. Infected
cells were by scored by VP1 expression. The graph represents the percentage of infected cells from three or more experiments, each which have been normalized to
scrambled siRNA control sequence (Scr). np-value of siRNA treatment compared to Scr control is o0.02. Error bars on bar graphs represent the SEM.
S.J. Bouley et al. / Virology 456-457 (2014) 87–95 91
Fig. 5. BKPyV localizes to the autophagosome. (A–D) Vero cells were plated on coverslips and transfected with 0.5 mg LC3-GFP plasmid and incubated for 24 h. Cells were
then infected with BKPyV-AF633 at 37 1C for 3 h, ﬁxed and mounted onto slides using DAPI mounting media. Cells were analyzed for appearance of LC3-positive
autophagosomes (green) and infection of labeled BKPyV (red) use a Zeiss 710 confocal microscope and Zen imaging software. Images analyzed using ImageJ image analysis
software. Four representative cells show that BKPyV-Af633 resides within the LC3-GFPþ autophagosome and with smaller LC3-GFPþ punctae (magniﬁcation 630X). (A and B)
(ii) An orthogonal Z slice of (iii) (along yellow x-axis). (iii) A magniﬁed image of BKPyV and LC3-GFPþ as shown in (i). (iv) An orthogonal Z slice of (iii) (along yellow
y-axis). (E) LC3-GFP transfected cells were scored for the pattern of LC3-GFP distribution (n¼60, left). BKPyV-633 infected/LC3-GFP transfected cells were scored for LC3-GFP
distribution (n¼60, middle). BKPyV-633 infected that showed colocalization with LC3-GFO were scored for pattern of LC3-GFP distribution (n¼60, right).
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autophagy inhibitors, high amino acid concentrations, and knock-
down of autophagy genes reduced BKPyV infection, while rapa-
mycin treatment led to an increase in BKPyV infection. BKPyV is
sensitive to autophagy inhibitors during the ﬁrst 8 h of infection, a
time period consistent with viral entry and intracellular trafﬁcking
(Eash and Atwood, 2005; Eash et al., 2004; Jiang et al., 2009).
Interestingly we did note that addition of autophagy inhibitors
from 24 to 48 h post infection increases BKPyV infection of Vero
cells (Fig. 3). We also observed a similar increase in infection levels
when autophagy inhibitors were added 16–24 h following infec-
tion (data not shown). From 16 to 48 h post infection, T-Ag
transcription and protein production, viral replication, and V-Ag
protein production occur in this sequential order (Jiang et al.,
2009). Therefore it is possible that at this time frame, autophagy
acts has an antiviral mechanism by degrading newly translated
viral proteins. Addition of autophagy inhibitors midway through
the viral lifecycle may allow more viral protein synthesis and
virion assembly to occur. Eukaryotic cells respond to stressful
stimuli using autophagy and the unfolded protein response.
Recent evidence suggests that Rab1 protein may have important
roles in both pathways (Chua and Tang, 2013). Therefore pharma-
cologically blocking autophagy between 16 h and 48 h post viral
challenge may elevate BKPyV infection by reducing the unfolded
protein response allowing translation to proceed despite ER-stress.
Using confocal immunoﬂuorescence, our data also shows that
BKPyV was found within LC3-positive structures 3 h following
infection (Fig. 5A and B). Strikingly, BKPyV infected cells correlated
with a change in the localization of LC3-GFP from a diffuse pattern
to a small and large punctate distribution pattern suggesting that
BKPyV has a mechanism to stimulate host autophagy (Fig. 5E).
Some of the early steps in the BKPyV life cycle have been
elucidated in recent years. BKPyV attaches to its host cell by
binding to a disialic acid-containing b-series ganglioside receptor
(GD3, GD2,GD1b, GT1b) (Neu et al., 2013; Low et al., 2006). Upon
caveolae-mediated endocytosis, BKPyV enters the cell and requires
some acidiﬁcation event in the ﬁrst few hours following infection
(Eash et al., 2004; Jiang et al., 2009). Dynamic microtubules are
thought to help shuttle viral particles to the ER where virus
localizes at 8–12 h following adsorption (Jiang et al., 2009). Within
the ER, capsid disassembly occurs. BKPyV also utilizes the protea-
some and ER-associated degradation pathway (ERAD) to help
BKPyV exit from the ER and for viral DNA accumulate in the
cytoplasm (Jiang et al., 2009; Bennett et al., 2013). Nuclear
transport of viral DNA then occurs.
This is the ﬁrst report indicating that autophagy plays a role in
BKPyV infection of host cells. Our study indicates that BKPyV localizes
to the autophagosome 3 h post infection and that autophagy aids in
productive BKPyV invasion of host cells. While the exact reason for
this BKPyV-autophagosome interaction has yet to be elucidated, there
are many possible explanations. First, an autophagosome may facil-
itate trafﬁcking the virus towards the ER for viral disassembly.
Autophagosomes use microtubules to shuttle themselves towards
the lysosome to and group together with other autophagosomes in
perinuclear regions (Jahreiss et al., 2008; Mackeh et al., 2013; Bouzas-
Rodriguez et al., 2012). Drug studies show that microtubule assemble
and disassembly is necessary for BKPyV infection (Eash and Atwood,
2005; Jiang et al., 2009). Therefore BKPyV may utilize the coordinated
interaction between the autophagosome and microtubules to be
shuttle closer to the ER. BKPyV does not seem to use the canonical
early to late endosomal pathway to reach the ER, so this alternative
trafﬁcking strategy is a possibility ((Eash and Atwood, 2005; Eash
et al., 2004; Jiang et al., 2009) personal communication with Mengxi
Jiang and Michael J. Imperiale).
Another second possibility is that BKPyV interacts with the
autophagosome to utilize the low pH and hydrolase-rich environ-
ment during the autophagosome–lysosome fusion process. Other
studies have shown that acidiﬁcation is necessary for viral infec-
tion (Mateo et al., 2013; Mackeh et al., 2013) Moreover, BKPyV
infection requires an acidiﬁcation event to occur within 2 h
following infection (Eash et al., 2004; Jiang et al., 2009). BKPyV
may utilize this low pH environment or speciﬁc enzymes that
become activated in low pH to modify its capsid or partially
degraded structural proteins. A third possibility is that stimulating
autophagy may promote a pro-survival cell response that primes
the cell to deal with the stress of a viral infection. In some cells
types, autophagy is reported to inhibit cell death, and this block is
cell death has been associated with greater viral yield (Kumar and
Rangarajan, 2009; Tovilovic et al., 2013; Tovilovic et al., 2013;
Joubert et al., 2012). Conversely for some viruses, activation of
autophagy leads to apoptosis, which increases the number of viral
particles for same virus species (Xi et al., 2013; Shai et al., 2013).
Autophagy is a complex process that affects viruses differently
depending on cell type, viral species, and viral life cycle stage. Our
observations suggest that autophagy plays a positive role in BKPyV
infection process. How exactly autophagy aids BKPyV and whether
these observations extend to other polyomavirus members,
including the wide array of recent discovered polyomaviruses,
warrant further investigation.
Methods
Cell and virus
Vero and HeLa cells (American Type Culture Collection; ATCC)
were maintained in a humidiﬁed 37 1C CO2 chamber in Eagle's
minimal essential medium (EMEM) (Mediatech) supplemented
with 1% penicillin/streptomycin (HyClone) and 5% and 10% heat
inactivated fetal bovine serum (Mediatech), respectively. The
Dunlop strain of BKPyV Gardner (ATCC) were propagated in Vero
cells and puriﬁed using CsCl as described previously (Raptis, 2001;
Eash et al., 2004). To label BKPyV, ﬂuorochrome conjugation with
10 μg/mL of AlexaFluor 633 carboxylic acid–succinimidyl ester
was added to BKPyV according to the manufacturer's labeling
procedure (MP00143; Molecular Probes). The infectivity of CsCl
puriﬁed BKV before and after labeling (BKPyV-633) was nearly
identical.
Infection of host cells
5103 cell were plated in 96-well culture plates. The following
day, cells were treated with multiple drugs that inﬂuence autop-
hagy levels, rapamycin, 3-methyladenine, baﬁlomycin-A, DMSO,
and spautin-1 (Sigma) before and after being infected with BKPyV
(MOI:5) for 1 h at 37 1C. 72 h post infection, cells were ﬁxed using
2% paraformaldehyde (EMB) and permeabilized using 0.5% Triton
X-100 (Shelton Scientiﬁc). To detect the number of infected cells
expressing viral protein, cells were incubated with the anti-V
antigen (V-Ag) monoclonal antibody PAB597, secondary Alexa-
Fluor-488-labeled goat anti-mouse antibody (Molecular Probes),
and then counterstained with DAPI-mounting media (Vector Labs).
The PAB597 hybridoma produced a monoclonal antibody against
the SV40 major capsid protein VP1 that cross-reacts with BKPyV
VP1. Infected cells were scored using a Nikon epiﬂuorescence
microscope (Eclipse E800; Nikon, Inc.). Approximately 20,000
cells, the entire surface of the 96 well, were screened for V-Ag
expression.
Amino acid supplementation
EMEM media was supplemented with additional the MEM
essential amino acids found in MEM media (50 MEM Amino
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Acid Solution from Life Technologies). The concentration of amino
acids found in 1 supplementation experiments is as follows:
1.2 mM L-arginine hydrochloride, 200 nM L-cysteine, 400 nM
L-histidine hrdrochloride-H20, 800 nM L-isoleucine, 3.6 mM
L-leucine, 790 nM L-lysine hydrochloride, 200 nM L-methionine,
400 nM L-phenylalanine, 800 nM L-threonine, 100 nM L-tryptophan,
400 nM L-tyrosine, and 800 nM L-valine. A 1X supplementation
corresponded to the manufacturer's suggested supplementation,
while 2 was twice this amount. NaOH was added to restore
supplemented media to pH 7.2. Cells were treated with these
media starting 24 h prior to infection and remained present for the
72 h following infection. During infection, BKPyV in EMEM with
2% FBS and no amino acid supplementation was added to cells.
Cell death assays
Vero cells were plated at 1104 in 96 well plates. Media
containing excessive amino acids or drugs were added to cells and
incubated for 24 h. To evaluate cell death using trypan blue
exclusion, cells were lifted from plate using trypsin for 5 min.
Media was added to inactivate trypsin. A 1:1 mixture of the cell
suspension was mixed with trypan blue. The total cell number
versus cells that appeared blue was scored using a hemacytometer.
To evaluate cell proliferation, 20 μl of a tertazolium compound
from CellTiter 96 Aqueous One Solution Cell Proliferation Assay
(MTS) (Promega) was added to media and cells after incubation
with amino acids or drugs for 24 h. The plate was incubated for 2 h
at 37 1C and then absorbance read at 450 nm using plate reader
(BioRad).
LC3 cellular distribution
Vero cells were plated at 1105 in a 6 well plate with a glass
coverslip and transfected with 1 μg of human LC3-EGFP (Addgene)
using 5 μl Fugene-HD (Jackson et al., 2005). The next day,
transfected cells were treated with complete media, serum starved
for 3 h with or without 5 mM 3-MA and the number of LC3þ
punctae in 80 cells was scored using immunoﬂuorescence and oil
immersion. The number of punctae per cell was also determined
for LC3-GFPþ transfected Vero cells treated with DMSO, and
100 nM of rapamycin with or without 5 μM spautin-1 for 24 h.
siRNA knockdown
1105 HeLa cells were plated onto a 12 well dish. The next day,
cells were transfected with 70 nM siRNA using 4 μl Lipofectamine
2000 and antibiotic free media (Invitrogen). The following siRNA
molecules used in this study consist of a mixture of three to ﬁve
different sequences that speciﬁcally target different regions of the
same gene: ATG7 (Hs_APG7L, SI02655373, Qiagen) negative con-
trol sequence (1027310, Qiagen), Beclin-1 (sc29797, Santa Cruz),
LC3B (sc43390, Santa Cruz) and negative control siRNA-A
(sc37007, Santa Cruz). 48 h following transfection with the siRNA
molecular, cells were either infected with BKPyV at an MOI:10 and
scored for VP1 expression using indirect immunoﬂuorescence or
protein lysates was collected.
Immunoblot analysis
Cells were plated at 1105 in 12 well dishes and transfected
with siRNA. Two days later, protein lysates were collected from
adherent cells by removing media and 150 μl of 2 Laemmli
buffer with 5% β-mercaptoethanol was added. After 5 min, cell
were scraped from the well surface, collected in an eppendorf tube
and, boiled for 10 min. Half of this sample was applied to a 4–15%
SDS-PAGE acrylamide gel (Biorad) and gel electrophoresis
conducted at 100 V. The protein on the gel was then transferred
to an equilibrated PVDF membrane (Biorad) using a semi-dry
transfer apparatus (Biorad) at 15 V for 15 min. The membrane was
blocked using 5% milk in Tris buffer saline with 1% Tween (TBST)
for 1 h. Antibodies in 1% milk in TBST were added to the blots and
incubated overnight at 4 1C. Antibodies used in this study were:
rabbit anti-ATG7 (2631, Cell Signaling), rabbit anti-Beclin-1 (sc-
11427, Santa Cruz), rabbit anti-GAPDH (14C10, Cell Signaling),
mouse anti-tubulin (sc-5286, Santa Cruz), goat anti-mouse Alexa-
Fluor 790 (A-11375, Technologies), and goat anti-rabbit AlexaFluor
680 (A-21076, Life Technologies). The TBST washed blots were
incubated with the secondary antibody in 1% milk in TBSTS for 1 h
at room temperature and developed using Li-Cor blot scanner and
densitometry measured using ImageJ.
Confocal microscopy
1105 Vero cells were plated onto a 6-well dish containing a
glass coverslip and transfected with 1 μg of LC3-GFP using 5 μl of
Fugene-HD. 24 h after transfection, cells were challenged with
BKPyV-633 (MOI 20) in 2% FBS EMEM media for 3 h. Cells were
then washed 2 with EMEM and ﬁxed using 2% paraformalde-
hyde for 15 min. Cells were counterstained with DAPI-mounting
media (Vector Labs) and applied to a microscope slide and
visualized using Zeiss LSM 510 Meta laser-scanning confocal
microscope. Images were analyzed using ImageJ image analysis
software. Colocalization of BKPyV-633 and LC3-GFPþ vesicles was
investigated in 60 cells. Cells were also scored for their predomi-
nate type of LC3 distribution in (1) all cells, (2) only cells where
BKPyV had entered, and (3) only cells where colocalization of
BKPyV-633 and LC3-GFP was observed.
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